Evidence map›Paper›PMID 18307968›Full record

ArticleVeterinary research

Slc11a1 (formerly Nramp1) and susceptibility to canine visceral leishmaniasis.

Elisenda Sanchez-Robert, Laura Altet, Mireia Utzet-Sadurni, Urs Giger, Armand Sanchez, Olga Francino

Open access · bronzeAbstract read
In one paragraph

Article in Veterinary research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 3 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Seroprevalence, clinical investigation, and risk factors associated withJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Is the Prevalence ofAnimals : an open access journal from MDPI · 2021
    Article
  13. Leishmania infantum in US-Born Dog.Emerging infectious diseases · 2020
    Article
  14. Article
  15. Feline leishmaniosis: Is the cat a small dog?Veterinary parasitology · 2018
    Review
  16. Biomarkers Associated WithFrontiers in cellular and infection microbiology · 2018
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Elisenda Sanchez-RobertVeterinary Molecular Genetics Service, Department of Animal and Food Science, Veterinary Faculty, Universitat Autonoma de Barcelona, 08193 Bellaterra, Barcelona, Spain. elisenda.sanchez@uab.cat
Laura Altet
Mireia Utzet-Sadurni
Urs Giger
Armand Sanchez
Olga Francino
Universitat Autònoma de Barcelona · ESBarcelona Biomedical Research Park · ESUniversity of Pennsylvania · US

Funding

X-LINKED SEVERE COMBINED IMMUNODEFICIENCY IN THE DOGP40RR002512 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI HASKINS, MARK E · 1985 to 2011
$7.6M
NCRR NIH HHS P40 RR002512NCRR NIH HHS RR02512
6 · The paper itself

Abstract

Visceral leishmaniasis is the most important zoonosis in Europe and it is caused by Leishmania infantum, a protozoan intracellular parasite. Canine visceral leishmaniasis (CVL) is endemic in the Mediterranean basin, Middle East, and South America, and is emerging within non endemic areas such as the United Kingdom and North America. We have analyzed 24 polymorphisms in the canine Slc11a1 (formerly NRAMP1) gene: 19 new polymorphisms characterized by direct sequencing from 40 dogs of different breeds and five polymorphisms previously described. Data analysis in a case-control study including 164 dogs of 19 different breeds revealed that two of the 24 polymorphisms were associated with increased risk for CVL: one intronic single nucleotide polymorphism (SNP) (A4549G in intron 6: odds ratio (OR) = 6.78, P = 0.001) and one silent SNP in exon 8 (C4859T: OR = 13.44, P = 0.004). In silico analysis of the significant SNP revealed that SNP in the promoter region affect putative transcription binding sites and SNP C4859T in exon 8 disrupts a putative exonic splicing enhancer (ESE). These results corroborate that Slc11a1 polymorphisms are associated with increased risk for CVL.

Indexed as

Leishmania infantumPolymorphism, Single NucleotideAnimalsCase-Control StudiesCation Transport ProteinsDNA PrimersDog DiseasesDogsGenetic Predisposition to DiseaseLeishmaniasis, VisceralNatural Resistance-associated Macrophage Protein 1PedigreePennsylvaniaPolymerase Chain ReactionSpainCation Transport ProteinsDNA PrimersNatural Resistance-associated Macrophage Protein 1

Identifiers

PMID18307968
PMCPMC2678959
OpenAlexW2130321920

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.